Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 4 (2007), Issue 4 (April)

1. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function.
   J Clin Oncol, 25(10): 1260-6. [Abstract] [Full-text]
2. Patient assessment of bowel function during and after pelvic radiotherapy: results of a prospective phase III North Central Cancer Treatment Group clinical trial.
   J Clin Oncol, 25(10): 1255-9. [Abstract] [Full-text]
3. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.
   J Clin Oncol, 25(10): 1183-9. [Abstract] [Full-text]
4. Patient-specific dosimetry of conventional and intensity modulated radiation therapy using a novel full Monte Carlo phase space reconstruction method from electronic portal images.
   Phys Med Biol, 52(8): 2277-99. [Abstract] [Full-text]
5. Dose delivered from Varian's CBCT to patients receiving IMRT for prostate cancer.
   Phys Med Biol, 52(8): 2267-76. [Abstract] [Full-text]
6. Registration of DRRs and portal images for verification of stereotactic body radiotherapy: a feasibility study in lung cancer treatment.
   Phys Med Biol, 52(8): 2157-70. [Abstract] [Full-text]
7. A feasibility study of using conventional jaws to deliver IMRT plans in the treatment of prostate cancer.
   Phys Med Biol, 52(8): 2147-56. [Abstract] [Full-text]
8. Optimization of megavoltage CT scan registration settings for brain cancer treatments on tomotherapy.
   Phys Med Biol, 52(8): N185-93. [Abstract] [Full-text]
9. The evolution of the conservative approach to breast cancer.
   Breast, 16(2): 120-9. [Abstract] [Full-text]
10. The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease.
    Eur J Surg Oncol, 33(3): 285-93. [Abstract] [Full-text]
11. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
    Int J Cancer, 120(11): 2491-8. [Abstract] [Full-text]
12. Angled screw holes for anterior posts and a frame-positioning device for gamma knife radiosurgery: allowing for better targeting of intracranial lesions.
    Neurosurgery, 60(4): 339-43; discussion 343-4. [Abstract] [Full-text]
13. Influence of nerve radiation dose in the incidence of trigeminal dysfunction after trigeminal neuralgia radiosurgery.
    Neurosurgery, 60(4): 681-7; discussion 687-8. [Abstract] [Full-text]
14. Symptomatic Chiari type I malformation after radiation therapy in an infant: case report.
    Neurosurgery, 60(4): E782; discussion E782. [Abstract] [Full-text]
15. A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone.
    Am J Clin Oncol, 30(2): 199-204. [Abstract] [Full-text]
16. Placement technique and the early complications of balloon breast brachytherapy: Magee-Womens Hospital experience.
    Am J Clin Oncol, 30(2): 152-5. [Abstract] [Full-text]
17. Treatment for microcarcinoma of the thyroid--clinical experience.
    Clin Nucl Med, 32(4): 279-81. [Abstract] [Full-text]
18. Accelerated radiotherapy with simultaneous integrated boost fractionation and intensity-modulated radiotherapy for advanced head and neck cancer.
    Otolaryngol Head Neck Surg, 136(4): 549-55. [Abstract] [Full-text]
19. The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397).
    Radiother Oncol, 83(1): 31-41. [Abstract] [Full-text]
20. Accuracy of image-guided radiotherapy of prostate cancer based on the BeamCath urethral catheter technique.
    Radiother Oncol, 83(1): 25-30. [Abstract] [Full-text]
21. Routine individualised patient dosimetry using electronic portal imaging devices.
    Radiother Oncol, 83(1): 65-75. [Abstract] [Full-text]
22. Prostate brachytherapy post-implant dosimetry: a comparison between higher and lower source density.
    Radiother Oncol, 83(1): 18-24. [Abstract] [Full-text]
23. Development of a TLD mailed system for remote dosimetry audit for (192)Ir HDR and PDR sources.
    Radiother Oncol, 83(1): 86-93. [Abstract] [Full-text]
24. On the dose to a moving target while employing different IMRT delivery mechanisms.
    Radiother Oncol, 83(1): 49-56. [Abstract] [Full-text]
25. The influence of geometrical changes on the dose distribution after I-125 seed implantation of the prostate.
    Radiother Oncol, 83(1): 11-7. [Abstract] [Full-text]
26. Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy.
    Radiother Oncol, 83(1): 3-10. [Abstract] [Full-text]
27. High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.
    J Clin Oncol, 25(11): 1396-402. [Abstract] [Full-text]
28. Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors.
    Radiother Oncol, 83(1): 57-64. [Abstract] [Full-text]
29. Music therapy as a non-pharmacological anxiolytic for paediatric radiotherapy patients.
    Australas Radiol, 51(2): 159-62. [Abstract] [Full-text]
30. Surface laser scanning to routinely produce casts for patient immobilization during radiotherapy.
    Australas Radiol, 51(2): 150-3. [Abstract] [Full-text]
31. What is the best adjuvant treatment for very young patients with medulloblastoma?
    Expert Rev Neurother, 7(4): 373-81. [Abstract] [Full-text]
32. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
    BMC Cancer, 7: 53. [Abstract] [Full-text]
33. Recto-urethral fistula following brachytherapy for localized prostate cancer.
    Colorectal Dis, 9(4): 328-31. [Abstract] [Full-text]
34. Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the Expanded Prostate Cancer Index Composite.
    J Urol, 177(5): 1856-61. [Abstract] [Full-text]
35. Patterns of local failure following prostate brachytherapy.
    J Urol, 177(5): 1759-63; duscussion 1763-4. [Abstract] [Full-text]
36. A nonsurgical technique for blood access in extracorporeal affinity adsorption of antibodies in rats.
    Artif Organs, 31(4): 312-6. [Abstract] [Full-text]
37. Dynamic dose-feedback prostate brachytherapy in patients with large prostates and/or planned transurethral surgery before implantation.
    BJU Int, 99(5): 1066-71. [Abstract] [Full-text]
38. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas.
    J Neurooncol, 82(3): 297-303. [Abstract] [Full-text]
39. Oral histoplasmosis after radiation therapy for laryngeal squamous cell carcinoma.
    J Am Acad Dermatol, 56(5): 871-3. [Abstract] [Full-text]
40. Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience.
    J Neurooncol, 82(3): 273-9. [Abstract] [Full-text]
41. Development and characteristics of the HANARO neutron irradiation facility for applications in the boron neutron capture therapy field.
    Phys Med Biol, 52(9): 2553-66. [Abstract] [Full-text]
42. Quantification of beta+ activity generated by hard photons by means of PET.
    Phys Med Biol, 52(9): 2515-30. [Abstract] [Full-text]
43. Calculation of the positron distribution from 15O nuclei formed in nuclear reactions in human tissue during proton therapy.
    Phys Med Biol, 52(9): 2483-98. [Abstract] [Full-text]
44. Improvement of field matching in segmented-field electron conformal therapy using a variable-SCD applicator.
    Phys Med Biol, 52(9): 2459-81. [Abstract] [Full-text]
45. A delivery transfer function (DTF) analysis for helical tomotherapy.
    Phys Med Biol, 52(9): 2355-65. [Abstract] [Full-text]
46. (212)Pb@C(60) and its water-soluble derivatives: synthesis, stability, and suitability for radioimmunotherapy.
    J Am Chem Soc, 129(16): 5131-8. [Abstract] [Full-text]
47. Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.
    Int J Clin Oncol, 12(2): 99-110. [Abstract] [Full-text]
48. New bioerodable thermoresponsive polymers for possible radiotherapeutic applications.
    J Control Release, 119(1): 25-33. [Abstract] [Full-text]
49. Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development.
    J Neurooncol, 83(1): 33-8. [Abstract] [Full-text]
50. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.
    J Vasc Interv Radiol, 18(4): 553-61; quiz 562. [Abstract] [Full-text]
51. Intracranial arteriovenous malformations treated with linear accelerator-based conformal radiosurgery: clinical outcome and prediction of obliteration.
    Surg Neurol, 67(5): 487-91; discussion 491-2. [Abstract] [Full-text]
52. Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma.
    Biol Blood Marrow Transplant, 13(5): 594-600. [Abstract] [Full-text]
53. Uncertainty estimation in intensity-modulated radiotherapy absolute dosimetry verification.
    Int J Radiat Oncol Biol Phys, 68(1): 301-10. [Abstract] [Full-text]
54. Hypoxia dose painting by numbers: a planning study.
    Int J Radiat Oncol Biol Phys, 68(1): 291-300. [Abstract] [Full-text]
55. Target coverage in image-guided stereotactic body radiotherapy of liver tumors.
    Int J Radiat Oncol Biol Phys, 68(1): 282-90. [Abstract] [Full-text]
56. Feasibility of image registration and intensity-modulated radiotherapy planning with hyperpolarized helium-3 magnetic resonance imaging for non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 68(1): 273-81. [Abstract] [Full-text]
57. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer.
    Int J Radiat Oncol Biol Phys, 68(1): 126-35. [Abstract] [Full-text]
58. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
    Int J Radiat Oncol Biol Phys, 68(1): 13-23. [Abstract] [Full-text]
59. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys, 68(1): 103-10. [Abstract] [Full-text]
60. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer.
    Lung Cancer, 56(2): 229-34. [Abstract] [Full-text]
61. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
    Int J Radiat Oncol Biol Phys, 68(1): 159-65. [Abstract] [Full-text]
62. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer.
    Int J Radiat Oncol Biol Phys, 68(1): 166-71. [Abstract] [Full-text]
63. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Int J Radiat Oncol Biol Phys, 68(1): 94-102. [Abstract] [Full-text]
64. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma.
    Int J Radiat Oncol Biol Phys, 68(1): 144-50. [Abstract] [Full-text]
65. Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beam.
    Int J Radiat Oncol Biol Phys, 68(1): 34-40. [Abstract] [Full-text]
66. Quantification of trade-off between parotid gland sparing and planning target volume underdosages in clinically node-negative head-and-neck intensity-modulated radiotherapy.
    Int J Radiat Oncol Biol Phys, 68(1): 136-43. [Abstract] [Full-text]
67. Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey.
    Lung Cancer, 56(2): 235-45. [Abstract] [Full-text]
68. Radioguided parathyroidectomy for recurrent parathyroid cancer.
    Clin Nucl Med, 32(5): 358-60. [Abstract] [Full-text]
69. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.
    Radiology, 243(2): 493-9. [Abstract] [Full-text]
70. Safety of radiosurgery applied to conditions with abnormal tumor suppressor genes.
    Neurosurgery, 60(5): 860-4; discussion 860-4. [Abstract] [Full-text]
71. Gamma knife surgery for facial nerve schwannomas.
    Neurosurgery, 60(5): 853-9; discussion 853-9. [Abstract] [Full-text]
72. Stereotactic radiosurgery: adjacent tissue injury and response after high-dose single fraction radiation. Part II: Strategies for therapeutic enhancement, brain injury mitigation, and brain injury repair.
    Neurosurgery, 60(5): 799-814; discussion 799-814. [Abstract] [Full-text]
73. Stereotactic radiosurgery for the treatment of lung neoplasm: initial experience.
    Ann Thorac Surg, 83(5): 1820-4; discussion 1824-5. [Abstract] [Full-text]
74. Runaway implantable defibrillator--a rare complication of radiation therapy.
    Pacing Clin Electrophysiol, 30(5): 716-8. [Abstract] [Full-text]

© 2004-2008 Radiotherapy Research Today. All Rights Reserved.